Abstract
Aim: We aim to demonstrate that a surface-enhanced Raman spectroscopy (SERS) probe can be effectively used for protein detection in adrenal tumors. Materials & methods: The SERS probe method, which uses Au@Ag core-shell nanoparticles conjugated with a CgA antibody and a SERS reporter, was applied to detect CgA in adrenal tumors. Results: Our data reveal that the results of the CgA-SERS probe method were almost identical to those of western blot and superior to those of traditional immunohistochemistry. Conclusion: This study offers a novel strategy to detect CgA in adrenal tumors and provides more reliable protein test results than traditional immunohistochemistry analysis for adrenal pathologists, meaning that it might be a better clinical reference for the diagnosis of pheochromocytoma.
| Original language | English |
|---|---|
| Pages (from-to) | 397-407 |
| Number of pages | 11 |
| Journal | Nanomedicine |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2020 |
Keywords
- Raman imaging
- chromogranin A
- immunohistochemistry
- pheochromocytoma
- surface-enhanced Raman scattering
Fingerprint
Dive into the research topics of 'A surface-enhanced Raman scattering-based probe method for detecting chromogranin A in adrenal tumors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver